Radiation therapy for advanced lung cancer without chemo
Part of Cancer, Injuries & trauma, Lungs & breathing clinical trials.
This trial tests a special radiation schedule for people with locally advanced lung cancer who cannot have the usual chemo-radiation. It uses fewer, larger radiation doses to try to control the cancer while making treatment more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have locally advanced non-small cell lung cancer (confirmed by biopsy or cytology).
- You are not able to receive the standard treatment of chemotherapy plus radiation (definitive chemo-radiotherapy).
- You are in generally good daily functioning (able to care for yourself and up and about).
- You have not had chest radiation before that would significantly overlap with this treatment area.
- You do not have other uncontrolled cancer, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
This trial studies a different way to deliver radiation to people with locally advanced, non-operable non-small cell lung cancer. It may help by aiming to treat the tumor effectively with a different radiation timing and dose pattern.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial studies a new way of giving radiation therapy to the chest for lung cancer that is growing quickly. The approach uses a special schedule to damage the cancer more effectively, which might improve how well the treatment works.
This trial studies a new radiation technique called SFRT combined with chemoimmunotherapy for people with stage III lung cancer that did not respond well enough to the first round of treatment. The goal is to see if this combination can make the cancer shrink more effectively.
This trial tests a new way of giving radiation (in high and low doses) together with chemotherapy and immunotherapy to treat advanced non-small cell lung cancer. The goal is to see if this combination can shrink tumors and help patients live longer.
Hear when a new Non-small Cell Lung Cancer Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.